Clinical UpdatesMedical Product Safety Alerts

An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys.… »   

Antibiotics appear to be frequently prescribed to individuals with advanced dementia in nursing homes, especially in the two weeks before… »   

Aromatase inhibitors, a class of drugs used to ward off the recurrence of breast cancer after surgery, increase the risk… »   

Two researchers from National Brain Research Center (NBRC) suggest that a common antibiotic called minocycline may prevent children from death… »   

Potentially deadly staph bacteria may be easily defeated by the body’s own immune system once stripped of their golden hue… »   

British regulators said Thursday they have approved two proposals for research using human embryos derived from animal eggs.

… »   

The Vanderbilt physician who in the late 1980s established the antipsychotic drug clozapine as the gold standard for treating patients… »   

University of Kentucky researchers have discovered a possible added benefit of a novel new drug that lowers blood pressure.

U.S. government labs will start moving to non-animal methods such as cells and computer models to test chemicals, drugs and… »   

Patients with fibromyalgia treated with a synthetic form of marijuana, nabilone, showed significant reductions in pain and anxiety in a… »   

Weeks before a damaging report on the diabetes drug Avandia (rosiglitazone) was to appear in The New England Journal of… »   

Administering flu vaccines under the tongue may be more effective and offer more protection than injecting or inhaling the drug,… »   

Celebrex, an arthritis drug in the same class as the recalled painkiller Vioxx, caused irregular heartbeats in fruit flies and… »   

Regulators said Friday they would review whether to take action over Merck & Co Inc’s and Schering-Plough Corp’s popular cholesterol… »   

Drug maker Obecure has completed the treatment of patients in its phase II obesity trial. The company expects to… »